Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
CorEvitas Launches its Ninth Clinical Registry and First of Its Kind in Alopecia Areata
Anivive Announces Former Latham & Watkins LLP Office Managing Partner Jim Beaubien to their Board of Directors
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update
Outlook Therapeutics® to Present at the Virtual Investor 2023 Companies to Watch Event
Rigel Pharmaceuticals Provides Business Update
Daré Bioscience Announces Positive Pharmacokinetic (PK) Results from the DARE-HRT1 Phase 1 / 2 Study that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause
VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System
Diadem Reports New Data Showing Its AlzoSure® Predict Blood Test Can Accurately Identify "Rapid Progressors" Who Will Develop Alzheimer's Disease Within Two Years
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023
 12   13   14   15   16     17    18   19   20   21   22 
 <<   <   >   >>